BRD4 and cancer: In line with our speculation, cRGD-P/DOX-induced BRD4 expression is responsible for DOX resistance, and the BRD4 degrader ARV-825 could relieve drug resistance to improve the cytotoxic effect of DOX in the treatment of cancer.